Navigation Links
Pfizer Enters Into Agreement to Acquire 40 Percent Stake in Teuto in Brazil
Date:10/20/2010

sive distribution network and have the right to commercialize them under Teuto's own brand in Brazil.

In 2008, the global generics marketplace represented US$750 billion and is anticipated to grow up to US$920 billion by 2013, with the bulk of this growth generated in emerging markets. Today, branded and unbranded generics account for approximately 60 percent of the value of the Brazilian retail pharmaceutical market fueled by the increased purchasing power of growing middle and lower-middle income patients.

"We believe this partnership will enable both companies to effectively build upon one another's core capabilities and areas of expertise to help address the needs of more patients than ever before," said Jean-Michel Halfon, president of Pfizer's Emerging Markets Business Unit.  "This agreement demonstrates Pfizer's commitment to pursue focused investments in key emerging markets to accelerate our growth and increase patient access to high-quality medicines."

"Teuto's partnership with Pfizer is very complementary to our business goals.  It will expand our product portfolio and address the needs of the changing customer base," said Marcelo Henriques, chief executive officer of Teuto Laboratories.

The stake in Teuto demonstrates Pfizer's commitment to continue its expansion in emerging markets through customer-focused efforts by increasing access and affordability, partnering with other companies that offer diverse areas of expertise and leveraging the company's capabilities to build upon local markets.  

The transaction is subject to customary closing conditions and is expected to close by the end of fourth-quarter 2010.

Pfizer's financial advisor for the transaction was Goldman Sachs Group, Inc. while Skadden, Arps, Slate, Meagher & Flom LLP and Pinheiro Neto Advogados were its legal advisors.  Banco BTG Pactual SA served as Teuto's financial advisor, while Machado, Meyer, Sendacz & Opice and
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
2. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
3. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
4. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
5. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
6. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
7. MannKind Addresses Pfizers Announcement Regarding Exubera
8. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
9. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
10. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
11. Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... LONDON , BERLIN and ... The global market has the potential to grow to ... leading provider of market research reports has announced pharma industry ... Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable ... in terms of US pricing structures and the anticipated approval ...
(Date:9/15/2014)... GENEVE , September 15, 2014 /PRNewswire/ ... des principaux fabricants européens de sortir ou ... marché ou au soutien réglementaire de la ... alcaloïdes tropaniques comme principes pharmaceutiques actifs (API), ... la nortropine, le méthylbromure d,homatropine, le bromhydrate d,homatropine, ...
(Date:9/14/2014)... DIEGO , Sept. 14, 2014 HUYA ... global development of China,s pharmaceutical ... Institute of Pharmaceutical Research (TIPR) to develop medical ... and the western world, for global markets. ... venture, to be known as TIPR-HUYA Advancing Innovative Medicines ...
Breaking Medicine Technology:Monoclonal Antibodies Market for Gastric and Esophageal Cancers to Double by 2019 2Monoclonal Antibodies Market for Gastric and Esophageal Cancers to Double by 2019 3Alchem International s'engage à poursuivre et étendre la production des principes pharmaceutiques actifs contenant des alcaloïdes tropaniques et à soutenir la réglementation pour combler l'écart d'approvisionnement 2Alchem International s'engage à poursuivre et étendre la production des principes pharmaceutiques actifs contenant des alcaloïdes tropaniques et à soutenir la réglementation pour combler l'écart d'approvisionnement 3HUYA Bioscience International and TIPR Announce Joint Venture to Develop Medical Innovation for Global Markets 2HUYA Bioscience International and TIPR Announce Joint Venture to Develop Medical Innovation for Global Markets 3HUYA Bioscience International and TIPR Announce Joint Venture to Develop Medical Innovation for Global Markets 4
... (Nasdaq: ARAY ), the premier radiation ... Especialidad in Monterrey, Mexico has starting treating patients with ... is the first center in Mexico now offering patients ... anywhere in the body. The CyberKnife System ...
... Jan. 17, 2012  Ventana Medical Systems, Inc. (Ventana), ... that it has entered into a strategic collaboration ... a molecular companion diagnostic test intended to identify ... Bayer antibody-drug conjugate (ADC). Ventana,s diagnostic immunohistochemistry platform ...
Cached Medicine Technology:First CyberKnife Robotic Radiosurgery System Goes Live in Mexico 2First CyberKnife Robotic Radiosurgery System Goes Live in Mexico 3First CyberKnife Robotic Radiosurgery System Goes Live in Mexico 4Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy 2Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy 3
(Date:9/15/2014)... September 15, 2014 PhySynergy, LLC, ... another new client partnership. PhySynergy will assume management ... this month. In addition to bringing strong leadership ... service capacity and anesthesia resources, by tapping into ... , “As we continue to invest in technologies ...
(Date:9/15/2014)... 15, 2014 Final Cut Pro X ... have announced a new Template the Qube Theme from Pixel ... a wide variety quality themes and the Qube theme adds ... Christian Austin, Pixel Film Studios CEO. “Qube theme has a ... Qube features intuitive controls that allow particle randomization, background color, ...
(Date:9/14/2014)... Petersburg, FL (PRWEB) September 15, 2014 Skin ... external factors like sun damage and not moisturizing properly. However, ... if skin has been cared for. , Two main reasons ... 2) Loss of hyaluronic acid in the skin , During ... and both of these are responsible for important moisture retention ...
(Date:9/14/2014)... Proper oral care requires about two ... found a way to teach children to brush their ... toothbrush encourages an effective brushing habit by ensuring that ... without overbrushing, eliminating guesswork and promoting independence and proper ... suitable for all children, and producible in design variations. ...
(Date:9/14/2014)... September 14, 2014 Top10BestSEOHosting.com always ... evaluating many web host suppliers carefully, the site ... and GoDaddy are the Best WordPress Hosting suppliers ... famous as a top web hosting provider, and ... is a web hosting provider known for its ...
Breaking Medicine News(10 mins):Health News:PhySynergy Wins Contract to Revive Anesthesia Services for Regional Hospital 2Health News:Announcing the Release of a New Template for Final Cut Pro X, The Qube Theme from Pixel Film Studios 2Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 2Health News:2 Reasons Skin Becomes Dryer with Age and What To Do About It, From Sublime Beauty® 3Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2
... IRVINE, Calif., Oct. 9 DogChannel.com, the premier,online destination ... Medical,Conditions section, where visitors can find what may be ... The symptom list, located at http://www.DogChannel.com/medical ... Rugh, DVM, Ph.D. of,Rocheport, Missouri. The section contains the ...
... Analysis of 38 studies found painkillers showed protective effect ... drugs (NSAIDs) are associated with a reduced risk for ... findings aren,t an invitation for all women to start ... don,t want that to happen here, for people to ...
... 9 The National Academy of,Neuropsychology (NAN) will be ... Conference to be held October 22nd,through 25th at The ... New York.,The event will kick off with a full ... October 21, which includes an athlete panel,featuring former NHL ...
... CRME TSX: COM VANCOUVER, Oct. ... TSX: COM) today announced that it has been ... that an End of Review,meeting with the U.S. ... November 14th, 2008 regarding the New Drug Application ...
... Tournament to be held at Woodmont,Country Club on Oct. ... Sandler,and his wife, Froma, are still dealing with the ... disease of unknown origin that has no,cure. Lisa died ... The Sandlers have turned their grief into action as ...
... The following was,released by the U.S. ... ceremony for the Alzheimer,s,Awareness 42-cent social awareness ... Rockefeller Neurosciences Institute,s http://www.brni.org new,research ... D. Rockefeller IV, U.S. Postal Service ...
Cached Medicine News:Health News:DogChannel.com Launches Online Guide to Dog Medical Conditions 2Health News:NSAIDs Might Lower Breast Cancer Risk 2Health News:NSAIDs Might Lower Breast Cancer Risk 3Health News:National Academy of Neuropsychology to Focus on Effects of Sports Concussions at 2008 Conference 2Health News:Cardiome Provides Regulatory Update 2Health News:Cardiome Provides Regulatory Update 3Health News:Parents Host Golf Tournament to Fund Cure for Disease That Claimed Daughter's Life 2Health News:Parents Host Golf Tournament to Fund Cure for Disease That Claimed Daughter's Life 3Health News:Postal Service to Issue Alzheimer's Awareness Stamp 2
The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
The ImagingPlanet 70 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgical micr...
... Manage and Retrieve a ... DVMR- office, the first digital ... the physician's office environment. DVMR ... of high-resolution cameras for simple ...
Research Grade Microscope Camera from ImagingPlanet Research Microscopy Group, a superior imaging technology that delivers increased image resolution and precise color accuracy at an affordable pric...
Medicine Products: